• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膜性肾病患者随访10年后结局的实验室、临床及病理组织学意义

Laboratory, Clinical, and Pathohistological Significance of the Outcomes of Patients with Membranous Nephropathy After 10 Year of Follow-Up.

作者信息

Baralić Marko, Gajić Selena, Kostić Mihajlo, Stojadinović Milorad, Filić Kristina, Bjelić Danka, Karadžić-Ristanović Vidna, Mrđa Ivana, Gavrilović Jovana, Ćujić Danica, Sič Aleksandar, Janković Stefan, Putica Ivan, Stankovic Sanja, Vićentijević Dušan, Životić Maja, Radojević-Škodrić Sanja, Pavlović Jelena, Bontić Ana, Kezić Aleksandra

机构信息

Clinic of Nephrology, University Clinical Center of Serbia, Pasterova 2, 11000 Belgrade, Serbia.

Faculty of Medicine, University of Belgrade, Dr Subotića Starijeg 8, 11000 Belgrade, Serbia.

出版信息

Life (Basel). 2025 Aug 1;15(8):1221. doi: 10.3390/life15081221.

DOI:10.3390/life15081221
PMID:40868869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12387156/
Abstract

Membranous nephropathy (MN) is the most prevalent cause of nephrotic syndrome (NS) in adults, and it can be primary (idiopathic) with an unknown cause or secondary due to a variety of conditions (lupus, infections, malignancies, medications, etc.). It progresses to chronic kidney disease (CKD) in up to 60% of patients, and 10 to 30% develop end-stage kidney disease (ESKD). This retrospective study examines the importance of specific factors, including baseline demographic and clinical data, kidney biopsy PH findings, and selected biochemical parameters, influencing MN outcomes after 10 years of follow-up. The cohort included 94 individuals in whom a diagnosis of MN was established by percutaneous biopsy of the left kidney's lower pole at the University Clinical Center of Serbia (UCCS) between 2008 and 2013. According to the outcomes, patients were divided into three groups: the recovery (Rec) group, with complete remission, including normal serum creatinine (Scr) and proteinuria (Prt), the group with development of chronic kidney disease (CKD), and the group with development of end-stage kidney disease (ESKD). Nephropathologists graded pathohistological (PH) results from I to III based on the observed PH findings. During the follow-up period, 33 patients were in the Rec group, CKD developed in 53 patients, and ESKD developed in 8 patients. Baseline creatinine clearance levels (Ccr), Scr, and uric acid (urate) were found to be significantly associated with the outcomes ( < 0.001). The lowest values of baseline Scr and urate were observed in the Rec group. The presence of acute kidney injury (AKI) or CKD at the time of kidney biopsy was associated with the more frequent development of ESKD ( = 0.02). Lower Ccr was associated with a higher likelihood of progressing to CKD (B = -0.021, = 0.014), whereas older age independently predicted progression to ESKD (B = 0.02, = 0.032). Based on this study, it was concluded that the most important biochemical and clinical factors that are associated with the outcomes of this disease are the values of Scr, Ccr, and urate and the existence of CKD at the time of kidney biopsy. Unlike most previous studies, the presence of HTN had no statistical significance in the outcome of the disease.

摘要

膜性肾病(MN)是成人肾病综合征(NS)最常见的病因,它可以是原发性(特发性)的,病因不明,也可以是继发于多种情况(狼疮、感染、恶性肿瘤、药物等)。高达60%的患者会进展为慢性肾脏病(CKD),10%至30%的患者会发展为终末期肾病(ESKD)。这项回顾性研究探讨了特定因素的重要性,包括基线人口统计学和临床数据、肾活检病理组织学(PH)结果以及选定的生化参数,这些因素对随访10年后MN的预后产生影响。该队列包括94名个体,2008年至2013年间在塞尔维亚大学临床中心(UCCS)通过经皮穿刺左肾下极活检确诊为MN。根据预后情况,患者被分为三组:完全缓解的恢复(Rec)组,包括血清肌酐(Scr)和蛋白尿(Prt)正常;慢性肾脏病(CKD)发展组;终末期肾病(ESKD)发展组。肾病理学家根据观察到的PH结果将病理组织学(PH)结果分为I至III级。在随访期间,33例患者属于Rec组,53例患者发展为CKD,8例患者发展为ESKD。发现基线肌酐清除率(Ccr)、Scr和尿酸(尿酸盐)水平与预后显著相关(<0.001)。Rec组观察到最低的基线Scr和尿酸盐值。肾活检时存在急性肾损伤(AKI)或CKD与ESKD更频繁的发生相关(=0.02)。较低的Ccr与进展为CKD的可能性较高相关(B=-0.021,=0.014),而年龄较大独立预测进展为ESKD(B=0.02,=0.0

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1ac/12387156/a0c129e76274/life-15-01221-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1ac/12387156/68d0adecd6fd/life-15-01221-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1ac/12387156/4fd71c8a2e2e/life-15-01221-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1ac/12387156/a0c129e76274/life-15-01221-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1ac/12387156/68d0adecd6fd/life-15-01221-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1ac/12387156/4fd71c8a2e2e/life-15-01221-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1ac/12387156/a0c129e76274/life-15-01221-g003.jpg

相似文献

1
Laboratory, Clinical, and Pathohistological Significance of the Outcomes of Patients with Membranous Nephropathy After 10 Year of Follow-Up.膜性肾病患者随访10年后结局的实验室、临床及病理组织学意义
Life (Basel). 2025 Aug 1;15(8):1221. doi: 10.3390/life15081221.
2
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.成人肾病综合征中原发性膜性肾病的免疫抑制治疗。
Cochrane Database Syst Rev. 2021 Nov 15;11(11):CD004293. doi: 10.1002/14651858.CD004293.pub4.
3
Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.成人肾病综合征特发性膜性肾病的免疫抑制治疗
Cochrane Database Syst Rev. 2014 Oct 16;2014(10):CD004293. doi: 10.1002/14651858.CD004293.pub3.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
Oral adsorbents for preventing or delaying the progression of chronic kidney disease.用于预防或延缓慢性肾脏病进展的口服吸附剂。
Cochrane Database Syst Rev. 2014 Oct 15;2014(10):CD007861. doi: 10.1002/14651858.CD007861.pub2.
6
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
7
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
8
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在患有早期(1 至 3 期)非糖尿病慢性肾脏病的成人中的应用。
Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD007751. doi: 10.1002/14651858.CD007751.pub3.
9
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.慢性肾脏病患者的合生菌、益生元和益生菌。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

本文引用的文献

1
Membranous Nephropathy.膜性肾病
J Clin Med. 2025 Jan 24;14(3):761. doi: 10.3390/jcm14030761.
2
Mendelian study on air pollution and membranous nephropathy outcomes associations.基于孟德尔随机化研究空气污染与膜性肾病结局的相关性。
Medicine (Baltimore). 2024 Sep 20;103(38):e39708. doi: 10.1097/MD.0000000000039708.
3
An Updated Review of Membranous Nephropathy.膜性肾病的最新综述
Indian J Nephrol. 2024 Mar-Apr;34(2):105-118. doi: 10.25259/ijn_317_23. Epub 2024 Apr 10.
4
C3aR-initiated signaling is a critical mechanism of podocyte injury in membranous nephropathy.C3aR 介引发的信号转导是膜性肾病足细胞损伤的关键机制。
JCI Insight. 2024 Jan 16;9(4):e172976. doi: 10.1172/jci.insight.172976.
5
Membranous nephropathy treatment standard.膜性肾病治疗标准。
Nephrol Dial Transplant. 2024 Feb 28;39(3):403-413. doi: 10.1093/ndt/gfad225.
6
Membranous nephropathy-diagnosis and identification of target antigens.膜性肾病——诊断和靶抗原鉴定。
Nephrol Dial Transplant. 2024 Mar 27;39(4):600-606. doi: 10.1093/ndt/gfad227.
7
Altered Intestinal Microbial Flora and Metabolism in Patients with Idiopathic Membranous Nephropathy.特发性膜性肾病患者肠道微生物群和代谢的改变
Am J Nephrol. 2023;54(11-12):451-470. doi: 10.1159/000533537. Epub 2023 Oct 4.
8
Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1/β-catenin pathway.Sirtuin 6 通过抑制 Wnt1/β-catenin 通路阻断肾素-血管紧张素系统,从而防止足细胞损伤。
Acta Pharmacol Sin. 2024 Jan;45(1):137-149. doi: 10.1038/s41401-023-01148-w. Epub 2023 Aug 28.
9
Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan-produced indole metabolites.乳杆菌属通过色氨酸产生的吲哚代谢物抑制芳香烃受体途径来改善膜性肾病。
Br J Pharmacol. 2024 Jan;181(1):162-179. doi: 10.1111/bph.16219. Epub 2023 Sep 19.
10
Membranous nephropathy.膜性肾病。
J Bras Nefrol. 2023 Apr-Jun;45(2):229-243. doi: 10.1590/2175-8239-JBN-2023-0046en.